Phase 2 Cirrhosis, Liver Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Liver DiseasesCirrhosis, LiverDecompensated Liver Cirrhosis+5 more
Resolution Therapeutics Limited30 enrolled14 locationsNCT06823713
Recruiting
Phase 2
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
CirrhosisCirrhosis, LiverCirrhosis Due to Hepatitis B+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)256 enrolled13 locationsNCT05832229
Recruiting
Phase 2
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
Hepatocellular CarcinomaCirrhosis, Liver
The University of Texas Health Science Center at San Antonio32 enrolled1 locationNCT06526104
Recruiting
Phase 2
EGCG for Hepatocellular Carcinoma Chemoprevention
Cirrhosis, Liver
University of Texas Southwestern Medical Center60 enrolled1 locationNCT06015022
Recruiting
Phase 2
Danazol for Treatment of Cytopenias in Patients With Cirrhosis
Cirrhosis, LiverCytopenia
University of Southern California10 enrolled1 locationNCT04873102
Recruiting
Phase 2
Liver Cancer Disparities in American Indian and Alaska Native Persons
Hepatocellular CarcinomaHepatitis BCirrhosis, Liver
University of Washington200 enrolled1 locationNCT05304234